Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials
2019 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials
Pielen, A.; Feltgen, N. ; Hattenbach, L.-O.; Hoerauf, H. ; Bertelmann, T. ; Quiering, C. & Vögeler, J. et al. (2019)
Current Eye Research, 45(5) pp. 604-614. DOI: https://doi.org/10.1080/02713683.2019.1679839
Documents & Media
Details
- Authors
- Pielen, Amelie; Feltgen, Nicolas ; Hattenbach, Lars-Olof; Hoerauf, Hans ; Bertelmann, Thomas ; Quiering, Claudia; Vögeler, Jessica; Priglinger, Siegfried; Lang, Gabriele E.; Schmitz-Valckenberg, Steffen; Wolf, Armin; Rehak, Matus
- Issue Date
- 2019
- Journal
- Current Eye Research
- ISSN
- 0271-3683
- eISSN
- 1460-2202
- Language
- English
